UBS keeps USD 19.00 target for Kenvue stock
Published on 10/20/2026 at 21:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst view and results
- UBS maintained a USD 19.00 price target and Hold rating on October 15, 2026.
- Kenvue reported second-quarter 2026 revenue of USD 3.955 billion, up 3.00 percent year over year.
- Kenvue stock costs EUR 17.07 at Lang & Schwarz on October 20, 2026 at 9:01 p.m. CEST, 1.85 percent above the Tradegate close of October 19, 2026.
- Kenvue is scheduled to report third-quarter results on November 11, 2026.
Kenvue (ISIN US49177J1025) drew a Hold rating from UBS analyst Peter Grom, who maintained a USD 19.00 price target in a report dated October 15, 2026, according to Markets Insider. The NYSE quote was USD 19.18 on October 20, 2026 at 3:03 p.m. EDT, placing the UBS target 0.94 percent below the price. Kenvue stock stood at EUR 17.07 at Lang & Schwarz on October 20, 2026 at 9:01 p.m. CEST, up 1.85 percent versus the Tradegate close of October 19, 2026 at EUR 16.76.
Revenue sets the operating base
Kenvue reported second-quarter 2026 net sales of USD 3.955 billion, an increase of 3.00 percent from the same quarter a year earlier. Diluted earnings per share rose 9.00 percent to USD 0.24, while adjusted diluted earnings per share increased 7.00 percent to USD 0.31, according to the company's August 6, 2026 release on Kenvue.
Price position on October 20
The NYSE quote stood 4.72 percent below its USD 20.13 52-week high and 36.80 percent above its USD 14.02 low on October 20, 2026. The same quote showed a USD 36.8 billion market capitalization, a price-to-earnings ratio of 22.06, a 5.00 percent dividend yield and volume of 10,687,944 shares.
Valuation and the next date
Barron's listed 15 analyst ratings and an average price target of USD 19.30 on October 20, 2026. That average was 0.63 percent above the NYSE price of USD 19.18. Kenvue is scheduled to report third-quarter 2026 results on November 11, 2026, according to TradingView.
Comparison with peers
Kenvue: up 1.85 percent versus the Tradegate close, price-to-earnings ratio 22.06, market capitalization USD 36.8 billion.
The Clorox Company (NYSE, USD): up 2.17 percent, price-to-earnings ratio 18.19, market capitalization USD 10.6 billion.
The Procter & Gamble Company (NYSE, USD): up 0.55 percent, price-to-earnings ratio 23.95, market capitalization USD 368.3 billion.
What the target says
UBS places its USD 19.00 target below the latest NYSE price, while the broader average of USD 19.30 sits above it. The upcoming November 11 report is the next dated test for revenue growth and earnings per share.
Kenvue stock after hours
Kenvue stock stood at EUR 17.07 at Lang & Schwarz on October 20, 2026 at 9:01 p.m. CEST, 1.85 percent above the Tradegate close of October 19, 2026 at EUR 16.76.
The further course of trading is shown by the continuously updated real-time quote of Kenvue stock.
Kenvue stock facts
- Company: Kenvue Inc.
- ISIN: US49177J1025
- Ticker: KVUE
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 20, 2026, 9:01 p.m. CEST): EUR 17.07
- Change versus Tradegate close: plus 1.85 percent
- Tradegate close (October 19, 2026): EUR 16.76
- Market capitalization: USD 36.8 billion (as of October 20, 2026)
- 52-week range: USD 14.02-20.13 (as of October 20, 2026)
- Sector / Industry: Consumer Defensive / Household & Personal Products
- Next earnings date: November 11, 2026
Market context: Market report S&P 500.
